Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaymaa Bahnassy

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Molecular Cancer Research : MCR|March 11, 2022
Unlocking the Mysteries of Lobular Breast Cancer Biology Needs the Right Combination of Preclinical ModelsShaymaa Bahnassy, Matthew J Sikora, Rebecca B Riggins
JCO Precision Oncology|March 13, 2025
Generalized Evolutionary Classifier for Evolutionary Guided Precision MedicineMatthew McCoy, Chen-Hsiang Yeang, Shaymaa Bahnassy, et al.
Cell Communication and Signaling : CCS|September 19, 2020
Constitutively active androgen receptor supports the metastatic phenotype of endocrine-resistant hormone receptor-positive breast cancerShaymaa Bahnassy, Hariprasad Thangavel, Maram Quttina, et al.
Oncotarget|April 24, 2016
SUMOylation of HP1α supports association with ncRNA to define responsiveness of breast cancer cells to chemotherapyFeng-Ming Lin, Santosh Kumar, Jing Ren, et al.
Scientific Reports|April 22, 2017
Novel SUMO-Protease SENP7S Regulates β-catenin Signaling and Mammary Epithelial Cell TransformationSamaneh Karami, Feng-Ming Lin, Santosh Kumar, et al.
Endocrinology|October 28, 2023
Unraveling Vulnerabilities in Endocrine Therapy-Resistant HER2+/ER+ Breast CancerShaymaa Bahnassy, Hillary Stires, Lu Jin, et al.
Biorxiv : the Preprint Server for Biology|September 4, 2023
Unraveling Vulnerabilities in Endocrine Therapy-Resistant HER2+/ER+ Breast CancerShaymaa Bahnassy, Hillary Stires, Lu Jin, et al.
Journal of the Endocrine Society|September 28, 2023
Riluzole Suppresses Growth and Enhances Response to Endocrine Therapy in ER+ Breast CancerAyodeji O Olukoya, Hillary Stires, Shaymaa Bahnassy, et al.
Cancer Research Communications|December 19, 2023
WNT4 Regulates Cellular Metabolism via Intracellular Activity at the Mitochondria in Breast and Gynecologic CancersJoseph L Sottnik, Madeleine T Shackleford, Sydney K Robinson, et al.
Biorxiv : the Preprint Server for Biology|October 28, 2024
Glutamate Transport Proteins and Metabolic Enzymes are Poor Prognostic Factors in Invasive Lobular CarcinomaTodd A Young, Shaymaa Bahnassy, Theresa C Abalum, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Molecular Cancer Research : MCR|March 11, 2022
Unlocking the Mysteries of Lobular Breast Cancer Biology Needs the Right Combination of Preclinical ModelsShaymaa Bahnassy, Matthew J Sikora, Rebecca B Riggins
JCO Precision Oncology|March 13, 2025
Generalized Evolutionary Classifier for Evolutionary Guided Precision MedicineMatthew McCoy, Chen-Hsiang Yeang, Shaymaa Bahnassy, et al.
Cell Communication and Signaling : CCS|September 19, 2020
Constitutively active androgen receptor supports the metastatic phenotype of endocrine-resistant hormone receptor-positive breast cancerShaymaa Bahnassy, Hariprasad Thangavel, Maram Quttina, et al.
Oncotarget|April 24, 2016
SUMOylation of HP1α supports association with ncRNA to define responsiveness of breast cancer cells to chemotherapyFeng-Ming Lin, Santosh Kumar, Jing Ren, et al.
Scientific Reports|April 22, 2017
Novel SUMO-Protease SENP7S Regulates β-catenin Signaling and Mammary Epithelial Cell TransformationSamaneh Karami, Feng-Ming Lin, Santosh Kumar, et al.
Endocrinology|October 28, 2023
Unraveling Vulnerabilities in Endocrine Therapy-Resistant HER2+/ER+ Breast CancerShaymaa Bahnassy, Hillary Stires, Lu Jin, et al.
Biorxiv : the Preprint Server for Biology|September 4, 2023
Unraveling Vulnerabilities in Endocrine Therapy-Resistant HER2+/ER+ Breast CancerShaymaa Bahnassy, Hillary Stires, Lu Jin, et al.
Journal of the Endocrine Society|September 28, 2023
Riluzole Suppresses Growth and Enhances Response to Endocrine Therapy in ER+ Breast CancerAyodeji O Olukoya, Hillary Stires, Shaymaa Bahnassy, et al.
Cancer Research Communications|December 19, 2023
WNT4 Regulates Cellular Metabolism via Intracellular Activity at the Mitochondria in Breast and Gynecologic CancersJoseph L Sottnik, Madeleine T Shackleford, Sydney K Robinson, et al.
Biorxiv : the Preprint Server for Biology|October 28, 2024
Glutamate Transport Proteins and Metabolic Enzymes are Poor Prognostic Factors in Invasive Lobular CarcinomaTodd A Young, Shaymaa Bahnassy, Theresa C Abalum, et al.
Pageof 1